Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Medical Facilities ( (TSE:DR) ) has issued an announcement.
Medical Facilities Corporation said it will publish its fourth quarter and full-year 2025 financial results before markets open on March 12, 2026, with the accompanying financial statements and management discussion to be made available on the company’s website and filed on SEDAR+ the same day. Management will discuss the results on an earnings call and live audio webcast that morning, which will include a question-and-answer session with equity analysts, signaling ongoing engagement with investors and analysts around the company’s performance and outlook.
The most recent analyst rating on (TSE:DR) stock is a Hold with a C$17.00 price target. To see the full list of analyst forecasts on Medical Facilities stock, see the TSE:DR Stock Forecast page.
Spark’s Take on TSE:DR Stock
According to Spark, TipRanks’ AI Analyst, TSE:DR is a Outperform.
The score is driven primarily by strong financial performance (high margins and strong cash conversion) and very attractive valuation (low P/E with a moderate dividend). Technicals are supportive due to price strength above key moving averages, but mixed momentum indicators limit the upside of the technical component.
To see Spark’s full report on TSE:DR stock, click here.
More about Medical Facilities
Medical Facilities Corporation is a Toronto-based healthcare company that, in partnership with physicians, owns and operates two highly rated specialty surgical hospitals in Arkansas and South Dakota in the United States. These facilities focus on scheduled surgical, imaging, diagnostic and other procedures, including primary and urgent care, generating revenue from fees charged for the use of their facilities.
Average Trading Volume: 25,066
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$287.3M
For an in-depth examination of DR stock, go to TipRanks’ Overview page.

